Julia M. W. Gee
Tenovus Centre for Cancer Research
Welsh School of Pharmacy
Cardiff University
Cardiff
United Kingdom
Name/email consistency: high
- Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications. Gee, J.M., Shaw, V.E., Hiscox, S.E., McClelland, R.A., Rushmere, N.K., Nicholson, R.I. Endocr. Relat. Cancer (2006)
- Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Gee, J.M., Robertson, J.F., Gutteridge, E., Ellis, I.O., Pinder, S.E., Rubini, M., Nicholson, R.I. Endocr. Relat. Cancer (2005)
- Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models. Gee, J.M., Hutcheson, I.R. Breast Cancer Res. (2005)
- Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer. Gee, J.M., Giles, M.G., Nicholson, R.I. Breast Cancer Res. (2004)
- Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization. Gee, J.M., Nicholson, R.I. Breast Cancer Res. (2003)
- ADAM metalloproteases and EGFR signalling. Gee, J.M., Knowlden, J.M. Breast Cancer Res. (2003)
- The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro. Gee, J.M., Harper, M.E., Hutcheson, I.R., Madden, T.A., Barrow, D., Knowlden, J.M., McClelland, R.A., Jordan, N., Wakeling, A.E., Nicholson, R.I. Endocrinology (2003)
- Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Gee, J.M., Robertson, J.F., Ellis, I.O., Nicholson, R.I. Int. J. Cancer (2001)
- Biological and clinical associations of c-jun activation in human breast cancer. Gee, J.M., Barroso, A.F., Ellis, I.O., Robertson, J.F., Nicholson, R.I. Int. J. Cancer (2000)
- Endocrine response and resistance in breast cancer: a role for the transcription factor Fos. Gee, J.M., Willsher, P.C., Kenny, F.S., Robertson, J.F., Pinder, S.E., Ellis, I.O., Nicholson, R.I. Int. J. Cancer (1999)
